Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and levodopa

pyrazines has been researched along with levodopa in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreeva, NI; Mashkovskiĭ, MD1
Jing, FC; Wang, DQ; Wang, W1
Balan, G; Barreiro, G; Boscoe, BP; Chen, L; Chenard, LK; Cianfrogna, J; Claffey, MM; Coffman, KJ; Drozda, SE; Dunetz, JR; Fonseca, KR; Galatsis, P; Grimwood, S; Lazzaro, JT; Mancuso, JY; Miller, EL; Reese, MR; Rogers, BN; Sakurada, I; Shaffer, CL; Skaddan, M; Smith, DL; Stepan, AF; Trapa, P; Tuttle, JB; Verhoest, PR; Walker, DP; Wright, AS; Zaleska, MM; Zasadny, K; Zhang, L1

Other Studies

3 other study(ies) available for pyrazines and levodopa

ArticleYear
[The pharmacologic basis of the antidepressive activity of the new psychotropic preparation pyrazidol].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1975, Volume: 75, Issue:3

    Topics: 5-Hydroxytryptophan; Acetylcholine; Amphetamine; Animals; Antidepressive Agents; Arecoline; Blood Pressure; Cats; Dogs; Drug Synergism; Epinephrine; Gastrointestinal Motility; Hexobarbital; Indoles; Levodopa; Nicotine; Norepinephrine; Phenethylamines; Pyrazines; Rabbits; Rats; Reserpine; Tryptamines

1975
[Effects of tetramethylpyrazine on brain oxidative damage induced by intracerebral perfusion of L-DOPA in rats with Parkinson's disease].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2007, Volume: 27, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catechols; Chromatography, High Pressure Liquid; Corpus Striatum; Hydroxybenzoates; Levodopa; Male; Microdialysis; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley

2007
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulat
    Journal of medicinal chemistry, 2014, Feb-13, Volume: 57, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Allosteric Regulation; Animals; Antiparkinson Agents; Biological Availability; Cell Membrane Permeability; Dogs; Dyskinesia, Drug-Induced; HEK293 Cells; Humans; Hypersensitivity, Delayed; Levodopa; Macaca fascicularis; Madin Darby Canine Kidney Cells; Male; Microsomes, Liver; Models, Molecular; Parkinson Disease; Pyrazines; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Structure-Activity Relationship

2014